Loading
Latest filing published 01 Mar 2006 for BIOENVISION INC, €54k.
No signal scores available.
Ian Abercrombie discloses dealings in Bioenvision Inc to SEC (Form 4). In total, 2 filings cover trades dated from 27 February 2006 to 28 February 2006.
The open-market record consists of 1 sale worth €360k, with no purchase. Outside the open market, there are 1 option exercise.
On 1 March 2006 came the latest disclosure, an option exercise for €54k in Bioenvision Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations